Longevity Health Holdings, Inc. (XAGE) stock price

Longevity Health Holdings, Inc. (XAGE) is a Consumer Defensive · Household & Personal Products company listed on NASDAQ. Price $0.17 (+0.06%), Market cap $0.00B, 52-week low–high $0.25 ~ $5.78.

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Longevity Health Holdings, Inc. are updated in real time on BlackAll Trade.

Longevity Health Holdings, Inc. financial summary

Key ratios · profitability · growth

Frequently asked questions

What is the current Longevity Health Holdings, Inc. (XAGE) stock price?

Longevity Health Holdings, Inc. trades at $0.17 (+0.06%). Real-time quotes and charts are available on BlackAll Trade.

What is the Longevity Health Holdings, Inc. (XAGE) market cap?

Longevity Health Holdings, Inc. has a market cap of about $0.00B.

What does Longevity Health Holdings, Inc. (XAGE) do?

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Eleva